Skip to main content
Mehow Innovative Ltd. logo

Mehow Innovative Ltd. — Investor Relations & Filings

Ticker · 301363 ISIN · CNE100005WP6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 498 across all filing types
Latest filing 2022-10-26 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 301363

About Mehow Innovative Ltd.

https://www.mehow.com

Mehow Innovative Ltd. specializes in the design, development, and manufacturing of high-precision medical devices and components. The company focuses on advanced manufacturing technologies, particularly Liquid Silicone Rubber (LSR) molding, multi-shot injection molding, and precision plastic components. Its core product portfolio includes respiratory care solutions, drug delivery systems, surgical instruments, and specialized medical consumables. Mehow provides comprehensive contract development and manufacturing organization (CDMO) services, encompassing product design, mold engineering, and automated assembly within controlled cleanroom environments. By integrating material science with precision engineering, the company supports global medical device manufacturers in producing complex, high-performance components for critical healthcare applications.

Recent filings

Filing Released Lang Actions
深圳市美好创亿医疗科技股份有限公司章程（上市后适用）
Governance Information Classification · 100% confidence The document is titled "章程" which translates to "Articles of Association" or "Company Bylaws" and is dated October 2022. It contains detailed provisions about the company's organizational structure, shareholder rights, board of directors, management, financial accounting, profit distribution, audit, notices, announcements, mergers, capital changes, and other governance matters. The content is comprehensive and legalistic, focusing on the internal rules and governance framework of the company after listing. There is no indication that this is an annual report, audit report, earnings release, or any other financial performance report. Instead, it is a governance document that sets out the company's internal rules and board structure. Therefore, the appropriate classification is Governance Information (CGR). The document length (15,000 characters) and detailed content confirm it is the full governance document, not just an announcement or summary.
2022-10-26 Chinese
深圳市美好创亿医疗科技股份有限公司2022年第三季度报告披露提示性公告
Report Publication Announcement Classification · 95% confidence The document is a short announcement (458 characters) indicating that the company's 2022 third quarter report has been approved and published on an official disclosure website. It does not contain the actual financial data or detailed report content but rather informs investors where to find the full report. According to the 'MENU VS MEAL' rule, such a brief notice about report availability is classified as a Report Publication Announcement (RPA).
2022-10-26 Chinese
深圳市美好创亿医疗科技股份有限公司独立董事关于第一届董事会第十五次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on matters discussed at the fifteenth meeting of the first board of directors of Shenzhen Meihua Chuangyi Medical Technology Co., Ltd. It discusses the use of raised funds for capital increase to a subsidiary and cash management of idle raised funds. The document references compliance with regulatory guidelines and company articles but does not contain financial statements or detailed financial data. It is a formal opinion related to board meeting matters rather than a full report or announcement of voting results. The document length is short (1146 characters), and it is not a report publication announcement or certification. This fits best under Board/Management Information (MANG) as it relates to board meeting matters and independent directors' opinions on company management decisions.
2022-10-26 Chinese
东兴证券股份有限公司关于深圳市美好创亿医疗科技股份有限公司使用部分募集资金向全资子公司增资以实施募投项目之核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed independent financial advisor's verification opinion regarding the use of part of the raised funds by Shenzhen Mehao Chuangyi Medical Technology Co., Ltd. to increase capital in its wholly-owned subsidiary for implementing a fundraising investment project. It includes references to regulatory approvals, fundraising amounts, investment projects, financial data of the subsidiary, and opinions from independent directors, supervisory board, and the sponsor institution. The document is not a full annual or interim report, nor is it a brief announcement or a certification. It is a specialized audit or verification report related to the use of raised funds and compliance with regulatory requirements. This fits the definition of an Audit Report / Information (AR) filing, which includes standalone audit reports and applied accounting principles related to specific financial matters, excluding full annual reports. The document length (3777 characters) and content confirm it is a substantive report rather than a mere announcement or certification.
2022-10-26 Chinese
2022年三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "深圳市美好创亿医疗科技股份有限公司2022 年第三季度报告" which translates to "Shenzhen Mehao Chuangyi Medical Technology Co., Ltd. 2022 Third Quarter Report." It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and shareholder information for the third quarter of 2022. The document explicitly states it is a quarterly report and includes comprehensive financial statements and analysis for a period shorter than a full fiscal year. It is not an announcement or a brief summary but a full financial report. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2022-10-26 Chinese
美好医疗：关于变更公司注册资本、公司类型、修订《公司章程》并办理工商登记的公告（2022-005）
Regulatory Filings Classification · 95% confidence The document is an official announcement regarding changes in the company's registered capital, company type, and amendments to the company's articles of association (company charter). It references approvals from regulatory bodies (China Securities Regulatory Commission and Shenzhen Stock Exchange) related to the company's initial public offering and listing. The document includes details about the share capital increase and changes to the company type to a listed joint-stock company. It also mentions the board meeting resolutions and the updated company charter. The document is relatively short (1502 characters) and serves as a formal announcement of corporate changes and regulatory approvals rather than a full financial report or detailed filing. It does not contain financial statements or detailed financial analysis. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2022-10-26 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.